West Pharmaceutical Services, Inc. (WST)
NYSE: WST · IEX Real-Time Price · USD
388.29
+13.14 (3.50%)
Apr 23, 2024, 12:24 PM EDT - Market open
WST Stock Forecast
Stock Price Forecast
The 5 analysts with 12-month price forecasts for WST stock have an average target of 435.2, with a low estimate of 375 and a high estimate of 536. The average target predicts an increase of 12.08% from the current stock price of 388.29.
Analyst Consensus: Strong Buy
* Price targets were last updated on Feb 16, 2024.
Analyst Ratings
The average analyst rating for WST stock from 5 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Nov '23 | Dec '23 | Jan '24 | Feb '24 | Mar '24 | Apr '24 |
|---|---|---|---|---|---|---|
| Strong Buy | 1 | 1 | 1 | 2 | 2 | 2 |
| Buy | 2 | 2 | 2 | 2 | 2 | 2 |
| Hold | 2 | 2 | 2 | 1 | 1 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 5 | 5 | 5 | 5 | 5 | 5 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| UBS | UBS | Hold Maintains $400 → $375 | Hold | Maintains | $400 → $375 | -3.42% | Feb 16, 2024 |
| Keybanc | Keybanc | Buy Maintains $440 → $470 | Buy | Maintains | $440 → $470 | +21.04% | Feb 13, 2024 |
| Jefferies | Jefferies | Hold → Strong Buy Upgrades $323 → $536 | Hold → Strong Buy | Upgrades | $323 → $536 | +38.04% | Feb 7, 2024 |
| Stephens & Co. | Stephens & Co. | Buy Maintains $420 → $390 | Buy | Maintains | $420 → $390 | +0.44% | Oct 27, 2023 |
| Keybanc | Keybanc | Buy Maintains $415 → $440 | Buy | Maintains | $415 → $440 | +13.32% | Aug 30, 2023 |
Financial Forecast
Revenue This Year
3.04B
from 2.95B
Increased by 3.09%
Revenue Next Year
3.32B
from 3.04B
Increased by 9.08%
EPS This Year
7.70
from 7.88
Decreased by -2.33%
EPS Next Year
9.14
from 7.70
Increased by 18.80%
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 3.2B | 3.5B | 3.8B | 4.2B | 5.0B |
| Avg | 3.0B | 3.3B | 3.6B | 4.0B | 4.8B |
| Low | 2.9B | 3.2B | 3.4B | 3.9B | 4.6B |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 7.5% | 15.2% | 15.0% | 17.1% | 22.9% |
| Avg | 3.1% | 9.1% | 8.2% | 12.7% | 18.2% |
| Low | -0.3% | 4.4% | 2.7% | 9.3% | 14.7% |
EPS Forecast
| EPS | 2024 | 2025 | 2026 | 2027 |
|---|---|---|---|---|
| High | 8.28 | 9.98 | 11.34 | 12.63 |
| Avg | 7.70 | 9.14 | 10.22 | 12.15 |
| Low | 7.35 | 8.37 | 9.45 | 11.79 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 | 2027 |
|---|---|---|---|---|
| High | 5.1% | 29.6% | 24.0% | 23.6% |
| Avg | -2.3% | 18.8% | 11.8% | 18.9% |
| Low | -6.7% | 8.7% | 3.3% | 15.4% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.